Vertex Pharmaceuticals is known for its cystic fibrosis drugs, but the company aims to diversify with a pipeline that reaches more therapeutic areas. CEO Reshma Kewalramani explained Vertex’s strategy during the World Medical Innovation Forum in Boston. The post Pain Meds, Cell Therapies & More: Vertex Pharma CEO Talks About What’s Next After Cystic Fibrosis…
Five days after taking the oath of his office, Robert F. Kennedy Jr. addressed HHS staffers
Experts believe value-based care won’t ever reach scale unless fundamental barriers are addressed — including voluntary models, misaligned payer incentives, excessive metrics and weak employer engagement. The post What’s Standing in the Way of Healthcare Payment Reform? appeared first on MedCity News.
Open Enrollment for 2025 Marketplace coverage starts November 1. Open Enrollment is right around the corner. Make sure you’re ready. Image Did you: Gather basic information (PDF, 163 KB)? You can fill out your application faster if you’re ready with information like birthdates and Social Security Numbers (SSNs).Check to see if you might save on…
That is the question considered by Wouters and Kuha (2024) in a recent Health Affairs article. The authors use IQVIA data between 1982 and 2024 on the timing of drug launches and estimate median delay times using a Kaplan Meier estimates. They find that: From the first launch globally, the median time to availability was…
Bristol Myers Squibb’s Cobenfy failed to outdistance a placebo in a Phase 3 test that evaluated the drug as an adjunct to antipsychotics in schizophrenia patients. Last September, the FDA approved Cobenfy as a standalone schizophrenia treatment. The post Bristol Myers Squibb Schizophrenia Drug Fails Pivotal Test as an Add-On to Antipsychotics appeared first on…
Experts say the fallout from HHS’ restructuring could set public health efforts back by decades by dismantling critical infrastructure. It’s also important to note that these changes cast serious doubt on the future of interoperability, pointed out Jason Prestinario, CEO of data platform Particle Health. The post What Does HHS’ Restructuring Mean for Interoperability In…
ISPOR recently released their award winners from their 2025 conference this May. Winners are listed below. I’m excited to announce that my podium presentation “Quantifying Treatment Value Using Alternative Health Benefit Metrics: A Case Study of Adjuvant Osimertinib for Elderly Patients with EGFR mutated NSCLC Following Resection” received an award for the Best General Podium…
The new standards emphasize the need for strong reporting and analytics that go beyond just credentialing automation. Healthcare organizations must look for solutions with comprehensive self-serve reporting capabilities to improve access and visibility into activities like potential changes to data, monitoring gaps, and more. The post NCQA’s Updated 2025 Standards Have Published: What it Means…
Organizations need to take a proactive approach to identify, prioritize and mitigate threats in real time. This means gaining visibility and control into all physical and virtual assets. The post A Preemptive Prescription to Cyber Exposure Management appeared first on MedCity News.